A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,125 shares of MEDP stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,125
Previous 3,230 3.25%
Holding current value
$1.09 Million
Previous $1.33 Million 21.58%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$320.58 - $457.29 $33,660 - $48,015
-105 Reduced 3.25%
3,125 $1.04 Million
Q2 2024

Jul 26, 2024

SELL
$372.0 - $424.34 $1,116 - $1,273
-3 Reduced 0.09%
3,230 $1.33 Million
Q1 2024

Apr 24, 2024

SELL
$284.87 - $413.31 $69,793 - $101,260
-245 Reduced 7.04%
3,233 $1.31 Million
Q4 2023

Feb 09, 2024

SELL
$227.52 - $312.68 $63,023 - $86,612
-277 Reduced 7.38%
3,478 $1.07 Million
Q3 2023

Oct 24, 2023

BUY
$233.98 - $281.67 $102,951 - $123,934
440 Added 13.27%
3,755 $909,000
Q2 2023

Jul 13, 2023

SELL
$187.26 - $240.17 $238,943 - $306,456
-1,276 Reduced 27.79%
3,315 $796,000
Q1 2023

May 11, 2023

BUY
$174.31 - $239.52 $256,584 - $352,573
1,472 Added 47.19%
4,591 $863,000
Q4 2022

Feb 08, 2023

BUY
$153.06 - $226.57 $222,243 - $328,979
1,452 Added 87.1%
3,119 $663,000
Q3 2022

Oct 17, 2022

BUY
$145.13 - $182.49 $17,270 - $21,716
119 Added 7.69%
1,667 $262,000
Q2 2022

Jul 13, 2022

SELL
$130.2 - $168.03 $4,296 - $5,544
-33 Reduced 2.09%
1,548 $231,000
Q1 2022

May 12, 2022

BUY
$138.87 - $214.31 $48,465 - $74,794
349 Added 28.33%
1,581 $258,000
Q4 2021

Feb 03, 2022

SELL
$182.74 - $227.9 $79,674 - $99,364
-436 Reduced 26.14%
1,232 $268,000
Q3 2021

Nov 02, 2021

BUY
$170.18 - $198.21 $283,860 - $330,614
1,668 New
1,668 $315,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.